CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 233 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,198,713 | +475.8% | 192,926 | +546.0% | 0.02% | +466.7% |
| Q4 2022 | $555,508 | -58.0% | 29,866 | -71.0% | 0.00% | -66.7% |
| Q3 2022 | $1,322,000 | +551.2% | 103,008 | +321.6% | 0.01% | +800.0% |
| Q1 2022 | $203,000 | -17.5% | 24,431 | -32.6% | 0.00% | 0.0% |
| Q4 2021 | $246,000 | +30.2% | 36,271 | -26.1% | 0.00% | -50.0% |
| Q1 2020 | $189,000 | +243.6% | 49,050 | +242.2% | 0.00% | – |
| Q2 2019 | $55,000 | -21.4% | 14,332 | -60.9% | 0.00% | – |
| Q4 2018 | $70,000 | -40.2% | 36,700 | +18.3% | 0.00% | -100.0% |
| Q3 2018 | $117,000 | +50.0% | 31,012 | +24.0% | 0.00% | – |
| Q2 2018 | $78,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |